Last updated on July 2016

Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD

Brief description of study

The objective of this study is to evaluate the efficacy, safety, pharmacodynamic, pharmacokinetic and immunogenic profiles of SA237 in patients with NMO and NMOSD

Clinical Study Identifier: NCT02073279

Contact Investigators or Research Sites near you

Start Over

Clinical trials information

Consultants in Neurology, Ltd.
Northbrook, IL United States
  Connect »